ACF 2023-2026 Sep 1, 2023 - Aug 31, 2026
All Projects (151)
Help 4 Health MSc studentships Nov 1, 2022 - Feb 29, 2024
Help 4 Health, through a competitive review process agreed to fund 3 MSc students (covering fees, a stipend of £16,062, and approximately £4k towards consumables).
Detection of novel biomarkers for identifying thyroid tumours using novel microfluidic technology - Brignall Trust Nov 1, 2022 - Oct 31, 2025
This PhD studentship was awarded by the Brignall Trust - PhD attached.
The funding is held by Alumni & Development- CRCJ29
The PhD student started in September 2022
Micreos Contribution to NBIC Studentship Jan 1, 2023 - Dec 31, 2026
Consumables top-up for the NBIC studentship, WT project: 3923886
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) (BRUIN-CLL-314) Apr 1, 2023 - Apr 30, 2025
Commercial phase III randomised controlled trial conducted on behalf of Eli Lilly and Company in Hull University Teaching Hospital.
Dr Allsup is the local principal investigator in his capacity as honorary NHS consultant.
UoH finance team to liai...
Read More about A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) (BRUIN-CLL-314).
Investigating the carcinogenic and epigenetic modulating effects of per- and poly-fluoroalkyl (PFAS) substances in breast cancer development Jan 1, 2024 - Dec 31, 2026
PFASs are used in numerous commercial and industrial applications. Subsequently, they are ubiquitously found in the environment and have been identified in human blood, breast milk and gut. They are endocrine disrupting chemicals which have been repo...
Read More about Investigating the carcinogenic and epigenetic modulating effects of per- and poly-fluoroalkyl (PFAS) substances in breast cancer development.
Wolfson Equipment bid 2023 - Confocal Imaging ZEISS Elyra 7 with Lattice SIM² Oct 1, 2024 - Sep 30, 2029
: A Targeted Approach To Reduce Risk of Blood Clotting in MPN Patients Oct 1, 2023 - Jan 31, 2025
A new mechanism has been identified where an intracellular switch, called AMP-activated protein kinase (AMPK) inhibits the function of constitutively active JAK2V617F protein responsible for disease in many patients with MPNs. Based on this observati...
Read More about : A Targeted Approach To Reduce Risk of Blood Clotting in MPN Patients.
HIKE: Development of a commercial urine test for the earlier detection of endometriosis Jul 1, 2023 - Mar 31, 2025
Endometriosis is a chronic incurable condition that is associated with debilitating pain and subfertility. It affects 190 million women worldwide, takes 8 years to diagnose and costs the UK economy £8.2 billion each year in loss of work (predomi...
Read More about HIKE: Development of a commercial urine test for the earlier detection of endometriosis.
Funding for Alice Fearn to attend the EACR annual conference Jun 1, 2023 - May 31, 2024
Funding for travel, accommodation and registration the EACR 2023 Congress, Torino, Italy. Poster presentation accepted
HIKE: Generating a Pre-Clinical Data Package to Support Commercialisation and Clinical Translation of Novel Regenerative Scaffolds for Chronic Wounds Jul 30, 2023 - Mar 31, 2024
This is an application to the University's HIKE funding scheme - MRC Confidence in Concept
HEIF: Pursuing a Climate Resilient and Net Zero Hull: Academics, Policymakers and Youth Voices Sep 4, 2023 - Jul 31, 2024
HEIF Project
The project focuses on positioning the University of Hull as a community anchor to co-develop and plan for a Climate Ready and Net Zero Hull. It will utilize the Yorkshire and Humber Climate Commission’s Climate Action Plan and co-dev...
Read More about HEIF: Pursuing a Climate Resilient and Net Zero Hull: Academics, Policymakers and Youth Voices.
HIKE: A Data Package to Support Clinical Translation of Novel Microwave Probes for Peripheral Arterial Disease (MICRO-PAD) Nov 1, 2023 - Mar 3, 2025
This project will combine HYMS/Hull’s biomedical and clinical expertise in vascular biology with Emblation’s track record in bringing medical devices to market to validate and commercialise novel patented microwave probes for treatment of peripheral...
Read More about HIKE: A Data Package to Support Clinical Translation of Novel Microwave Probes for Peripheral Arterial Disease (MICRO-PAD).
Microplastics as an emerging and iatrogenic threat in the healthcare setting Apr 1, 2024 - Mar 31, 2025
Microplastics as an emerging pollutant in healthcare settings, focussing on the operating room.
HIKE: Validating the measurement of respiration by mammalian embryos (HIKE) Oct 1, 2023 - Mar 31, 2025
This project is the first step on a journey that has the potential to revolutionise treatment of human infertility. It will generate vital confidence-in-concept data to confirm that the validated and established “Resipher system” (see below) is able...
Read More about HIKE: Validating the measurement of respiration by mammalian embryos (HIKE).
Patients and clinicians experiences of hair cycle modulation to facilitate wound healing: a qualitative study within a trial (SWAT) Jan 1, 2024 - Jun 30, 2025
Background: Chronic wounds, delayed healing and surgical site infection affect a significant number of patients. They substantially decrease quality of life and can lead to repeated hospital admission, social isolation, chronic pain limb loss and dea...
Read More about Patients and clinicians experiences of hair cycle modulation to facilitate wound healing: a qualitative study within a trial (SWAT).
Exploring the Potential of Nrf2-Controlled ECM in the Healing of Diabetic Wounds Jun 1, 2024 - May 31, 2025
Fully humanised model of ageing endothelium to study ageing-associated lung diseases: Apr 1, 2024 - Jan 1, 2025